, Tracking Stock Market Picks
Enter Symbol:
Mobile Telesystems (MBT) [hlAlert]

down 48.47 %

Mobile Telesystems (MBT) upgraded to Buy with price target $19 by Standpoint Research

Posted on: Thursday,  Oct 30, 2014  3:25 PM ET by Standpoint Research

Standpoint Research rated Buy Mobile Telesystems (NYSE: MBT) on 10/30/2014, when the stock price was $14.44. Since
then, Mobile Telesystems has lost 48.48% as of 11/27/2015's recent price of $7.44.
If you would have followed this Standpoint Research's recommendation on MBT, you would have lost 48.47% of your investment in 393 days.

Mobile TeleSystems OJSC is a provider of mobile cellular communications services in Russia, Uzbekistan, Turkmenistan and Armenia and Ukraine. During the year ended December 31, 2008, the Company had a subscriber base of 91.33 million (64.63 million in Russia, 18.12 million in Ukraine, 5.65 million in Uzbekistan, 0.93 million in Turkmenistan and 2.02 million in Armenia). In addition to standard voice services, the Company offers its subscribers value added services, including voice mail, short message service (SMS), general packet radio service (GPRS), augmented by enhanced data rates for GSM evolution (EDGE), high-speed downlink packet access (HSDPA), and various SMS- and GPRS/EDGE/HSDPA-based information and entertainment services (including multi media message service (MMS)). In October 2009, Sistema completed the sale of its 50.91% stake in Komstar - Obyedinennye TeleSistemy OAO to Mobile TeleSystems.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/30/2014 3:25 PM Buy
14.44 19.00
as of 10/17/2014
1 Week   
1 Month   
3 Months   
1 YTD up  25.26 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/27/2014 12:00 AM Hold
4/16/2014 12:00 AM Buy
15.75 20.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy